BTG3 and systemic lupus erythematosus: ANA (including anti-dsDNA antibodies) counts as a mandatory entry criterion if detected at least once at any interval of observation, as is stated in the 2019 EULAR/ACR SLE classification criteria (33); that is, ANA does not need to be timely linked to pathogenic conditions.